CDC advisory panel recommends COVID-19 vaccine for widespread use By Reuters



© Reuters. Coronavirus disease (COVID-19) vaccination study at the Research Centers of America in Hollywood

By Rebecca Spalding

(Reuters) -A U.S. Centers for Disease Control and Prevention advisory panel on Saturday recommended the nation’s first COVID-19 vaccine, helping clear the way for public health authorities to begin the largest vaccination campaign in U.S. history.

The Advisory Committee on Immunization Practices (ACIP) voted 11 to 0 to recommend the vaccine from Pfizer Inc (NYSE:) and BioNTech SE (NASDAQ:) as appropriate for Americans 16 and older. There were three abstentions due to prior conflicts of interest.

The Food and Drug Administration on Friday issued an emergency use authorization for the vaccine, clearing it for use by the general public.

The CDC is expected to consider and approve the recommendations by the panel in short order.

State and local public health authorities will use FDA and CDC guidance as they administer the first 2.9 million doses of the vaccine released to state, cities, and territories by the federal government.

ACIP already recommended that authorities should prioritize healthcare workers and nursing home residents for the first doses that become available.

It then falls on states and certain large cities to start administering the vaccine to local hospitals and nursing homes. Hospitals are expected to start vaccinating their employees as early as Monday.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.





Source link

Leave a Reply

Your email address will not be published. Required fields are marked *